IP Library › Assignment 043894/0343
Patent Assignment
Reel/Frame 043894/0343

Assignment of Assignor's Interest

Recorded: 2017-10-18 Pages: 6
Assignors
ANDERSON, DAVID R
Executed: 2016-03-22
VOLKMANN, ROBERT A
Executed: 2016-03-22
Assignee
LUC THERAPEUTICS
400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
N-Arylmethyl Sulfonamide Negative Modulators of NR2A
Patent: 9,963,434 →
Application: 15/024,870 →
Publication: US 2016/0311782
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 043894 Frame 0343. Assignor(S) Hereby Confirms the Assignment to Luc Therapeutics, Inc.. Mar 12, 2018
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.
To: LUC THERAPEUTICS, INC.
Reel/Frame 046812/0025 →
Change of Name Oct 18, 2018
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 047269/0745 →
Assignment of Assignor's Interest Aug 24, 2023
From: CADENT THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064691/0310 →